AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Empagliflozin/ Linagliptin in Ghana
4 products registered with FDA Ghana — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GLYXAMBI 25MG/5MG TABLETS | UNKNOWN-d9371693 | — | active | 1 Mar 2027 |
| GLYXAMBI 10MG/5MG TABLETS (Each film-coated tablet contains Empagliflozin/ Linagliptin 10/5mg) | UNKNOWN-107c2992 | — | active | 1 Mar 2027 |
| GLYXAMBI 25MG/5MG TABLETS | UNKNOWN-5a4ad768 | — | active | 1 Mar 2027 |
| GLYXAMBI 10MG/5MG TABLETS (Each film-coated tablet contains Empagliflozin/ Linagliptin 10/5mg) | UNKNOWN-17936626 | — | active | 1 Mar 2027 |
Empagliflozin/ Linagliptin — FDA Ghana Registration Details
FDA Ghana (Ghana) has 4 registered products containing Empagliflozin/ Linagliptin, of which 4 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Empagliflozin/ Linagliptin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.